Spectral AI, Inc. (MDAI)

CIK 0001833498 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
Latest FY-2025 8-K (2026-03-25) · 99.1
Q3-2025 —
Q2-2025 8-K (2025-08-13) · 99.1
Q1-2025 8-K (2025-05-14) · 99.1  |  8-K (2025-04-02) · 99.1
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 8-K (2024-03-29) · 99.1
Q3-2023 8-K (2023-11-14) · 99.1
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Document and Entity Information
—
Audit Information
—
Statements
Unaudited Condensed Consolidated Balance Sheets
—
Consolidated Balance Sheets
Unaudited Condensed Consolidated Balance Sheets (P)
—
Consolidated Balance Sheets (P)
Unaudited Condensed Consolidated Statements of Operations
—
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (loss)
—
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Deficit
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Equity (deficit)
—
Unaudited Condensed Consolidated Statements of Operations (P)
—
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (P)
—
Consolidated Statements of Changes In Stockholders Equity (deficit)
—
Consolidated Statements of Operations and Comprehensive Loss (P)
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Deficit (P)
—
Unaudited Condensed Consolidated Statements of Changes In Stockholders Equity
—
Consolidated Statements of Changes In Stockholders Equity (deficit) (P)
—
Unaudited Condensed Consolidated Statements of Cash Flows
—
Consolidated Statements of Cash Flows
—
Notes
Accrued Expenses
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Organization and Business Operations
—
Equity Issuance and Recapitalization
—
Fair Value Measurements
Income Taxes
Initial Public Offering
—
Insider Trading Arrangements
Leases
Nature of The Business
Nature of The Business and Presentation
—
Net (loss) Income Per Common Share
—
Net Income (loss) Per Common Share
—
Net Loss Per Common Share
Notes Payable
Organization, Nature of Business and Liquidity
—
Pay Vs Performance Disclosure
Private Placement
—
Recapitalization
Recent Accounting Pronoucements
—
Related Party Transactions
Research and Development Revenue
Stock-based Compensation
Stockholders Deficit
—
Stockholders Equity
Subsequent Events
Summary of Significant Accounting Policies
Warrants
—